3rd Global Cancer Summit – 2019

Dubai, United Arab Emirates
6 - 7 December 2019
The conference ended on 07 December 2019

Important Dates

Early Bird Deadline
23rd September 2019
Abstract Submission Deadline
1st November 2019
Abstract Acceptance Notification
15th November 2019
Final Abstract / Full Paper Deadline
30th November 2019

About GCS2019

The III Global Cancer Summit-2019 will once again gather all cancer control professions under one roof, at a crucial time in the global fight against cancer. Those high level cancer experts who attended the last Global Cancer Summit-2015 in Bengaluru, India and II Global Cancer Summit-2017 in Kuala Lumpur, Malaysia will confirm the III Global Cancer Summit-2019 has become a not-to-be missed event in the global health calendar. 


Cancer, Cancer research, Cancer and diet, Cancer treatments, Cancer biology, Cancer and cell biology, Cancer cells research, Cancer imaging, Cancer and oncology nursing, Cnc machines

Call for Papers

All investigators are invited to submit abstracts on topics pertaining to conference topics mentioned on the website. Authors are invited to submit abstract(s) using the submission form on this page. Abstracts should contain sufficient detail on the techniques used and the results, which will be shown. You will receive a confirmation when the abstract has been received. Please contact the conference secretariat if you did not receive confirmation within 5 working days. Submission implies the intent of at least one author to register, attend the symposium and present the paper (either 12+3 minutes orally or in poster format). Contributions will only be finally accepted after registration and payment of the conference fee. The abstract will be reviewed, and you will be notified of acceptance before 10th November 2019 after which the abstract submission page will be closed

Keep Up to Date with PaperCrowd

Sign up and follow your favorite conferences.

We are no longer accepting conference submissions on PaperCrowd. We apologise for any inconvenience.